PRESS RELEASES

SENTÉ Appoints Philippe Schaison to Board of Directors

SENTÉ Appoints Philippe Schaison to Board of Directors SAN DIEGO, Calif., October 24, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycan’s, today announced the appointment of Philippe Schaison to its Board of Directors effective immediately.  “We are…Continue Reading >>

SENTÉ Announces Issuance of a New United States Patent For Heparan Sulfate

San Diego, Calif., Oct. 17, 2016 — SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycan’s, today announced that the company has received a new patent grant, Process For The Purification Of Heparan Sulfate And Use Thereof In Cosmetological And Dermatological Preparations…Continue Reading >>

SENTÉ Appoints Virginia L. Vega, PhD As Vice President Research & Development and Physician Education

SENTÉ Appoints Virginia L. Vega, PhD As Vice President Research & Development and Physician Education SAN DIEGO, June 23, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announced the appointment of Virginia L. Vega, Ph.D. as…Continue Reading >>

SENTÉ Appoints Laurent Combredet As President & Chief Executive Officer

SENTÉ Appoints Laurent Combredet As President & Chief Executive Officer SAN DIEGO, February 9, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announced the appointment of Laurent Combredet as President and Chief Executive Officer. “Laurent is…Continue Reading >>

SENTÉ Completes $5M Capital Raise

SENTÉ Completes $5M Capital Raise Capital To Further Expand Commercial Operations And Broaden Product Portfolio SAN DIEGO, February 5, 2016 (GLOBE NEWSWIRE) – SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of glycosaminoglycans, today announced the close of a $5 million financing. This…Continue Reading >>

SENTÉ Announces Appointment of Michael Brower as Chief Financial Officer

SENTÉ Announces Appointment of Michael Brower as Chief Financial Officer SAN DIEGO, Nov. 5, 2014 (GLOBE NEWSWIRE) — SENTÉ a specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycosaminoglycans, today announced the appointment of Michael Brower to Chief Financial Officer. In his new role, Mr. Brower will be responsible…Continue Reading >>

Sente, Inc. Appoints Randy W. Kriech as Chief Commercial Officer

Sente, Inc. Appoints Randy W. Kriech as Chief Commercial Officer Aesthetic Industry Leader Brings Nearly Two Decades of Commercial and Marketing Expertise SAN DIEGO, July 22, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycoproteins, today announced the appointment…Continue Reading >>

Sente Inc., Appoints Mireille Gillings, Ph.D. to Its Board of Directors

Sente Inc., Appoints Mireille Gillings, Ph.D. to Its Board of Directors   Experienced Biopharmaceutical Industry Executive Adds to the Depth of the Company’s Board SAN DIEGO, June 17, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycoproteins, announced today…Continue Reading >>

Sente, Inc. Raises $5M in Series C Financing

Sente, Inc. Raises $5M in Series C Financing Capital to Fund Expanded Commercial Operations and Broaden Product Portfolio SAN DIEGO, June 2, 2014 (GLOBE NEWSWIRE) — Sente Inc., a privately held specialty aesthetics company pioneering the development of differentiated skincare products based on the science of glycoproteins, announced today the close of a $5 million…Continue Reading >>

Sente, Inc. Announces the Appointment of Michael York as President and Chief Executive Officer

Sente, Inc. Announces the Appointment of Michael York as President and Chief Executive Officer SAN DIEGO, Jul 11, 2013 (GLOBE NEWSWIRE) — Sente, Inc., a privately held cosmeceutical company engaged in the development of differentiated skincare products based on glycoproteins, announced today the appointment of Michael York as President, Chief Executive Officer and a member…Continue Reading >>

Sente, Inc. Appoints Distinguished Industry Veteran, Magda Marquet, Ph.D. to Its Board of Directors

Sente, Inc. Appoints Distinguished Industry Veteran, Magda Marquet, Ph.D. to Its Board of Directors Biotechnology Veteran Brings Deep Industry Expertise  SAN DIEGO, May 24, 2013 (GLOBE NEWSWIRE) — Sente, Inc., a privately held cosmeceutical company engaged in the development of differentiated skincare products based on glycoproteins, announced today that it has appointed Magda Marquet, Ph.D….Continue Reading >>

Sente, Inc. Raises $2.1M in Series B Equity Financing

Sente, Inc. Raises $2.1M in Series B Equity Financing  Funding to Support Commercial Operations and Additional Line Extensions to Sente’s Portfolio of Differentiated Skincare Products Based on Glycoproteins SAN DIEGO, May 14, 2013 (GLOBE NEWSWIRE) — Senté, Inc., a privately held cosmeceutical company engaged in the development of differentiated skincare products based on glycoproteins, announced…Continue Reading >>